Liu Y - Search Results

1

High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification.

Jiang X, Tang F, Zhang J, He M, Xie T, Tang H, Liu J, Luo K, Lu S, Liu Y, Lu J, He M, Wei Q. Jiang X, et al. Among authors: liu j, liu y. Front Oncol. 2023 Feb 10;13:991483. doi: 10.3389/fonc.2023.991483. eCollection 2023. Front Oncol. 2023. PMID: 36845726 Free PMC article.

2

To Explore the Mechanism of the GRM4 Gene in Osteosarcoma by RNA Sequencing and Bioinformatics Approach.

Pang Y, Zhao J, Fowdur M, Liu Y, Wu H, He M. Pang Y, et al. Among authors: liu y. Med Sci Monit Basic Res. 2018 Jan 17;24:16-25. doi: 10.12659/msmbr.908107. Med Sci Monit Basic Res. 2018. PMID: 29339716 Free PMC article.

3

Giant cell tumors combined with secondary aneurysmal bone cysts are more likely to develop postoperative recurrence: A retrospective study of 256 cases.

Tang H, Moro A, Feng W, Lai Y, Xiao Z, Liu Y, Wang K. Tang H, et al. Among authors: liu y. J Surg Oncol. 2019 Sep;120(3):359-365. doi: 10.1002/jso.25588. Epub 2019 Jun 20. J Surg Oncol. 2019. PMID: 31219620

4

Intraperitoneal extraosseous osteosarcoma: a case report and literatures review.

Wang T, Liao S, Ding X, Anil KC, Huang Q, Lin C, Mo J, Tang H, Liu Y. Wang T, et al. Among authors: liu y. BMC Musculoskelet Disord. 2020 Jul 11;21(1):452. doi: 10.1186/s12891-020-03429-5. BMC Musculoskelet Disord. 2020. PMID: 32653041 Free PMC article.

5

Corrigendum: Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma.

Liu Y, Feng W, Dai Y, Bao M, Yuan Z, He M, Qin Z, Liao S, He J, Huang Q, Yu Z, Zeng Y, Guo B, Huang R, Yang R, Jiang Y, Liao J, Xiao Z, Zhan X, Lin C, Xu J, Ye Y, Ma J, Wei Q, Mo Z. Liu Y, et al. Front Oncol. 2022 Nov 15;12:1077067. doi: 10.3389/fonc.2022.1077067. eCollection 2022. Front Oncol. 2022. PMID: 36457508 Free PMC article.

6

Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues.

Rothzerg E, Feng W, Song D, Li H, Wei Q, Fox A, Wood D, Xu J, Liu Y. Rothzerg E, et al. Among authors: liu y. Cancer Inform. 2022 Dec 5;21:11769351221140101. doi: 10.1177/11769351221140101. eCollection 2022. Cancer Inform. 2022. PMID: 36507075 Free PMC article.

7

Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8⁺ T cells in osteosarcoma.

Xie T, Feng W, He M, Zhan X, Liao S, He J, Qin Z, Li F, Xu J, Liu Y, Wei Q. Xie T, et al. Among authors: liu y. Exp Biol Med (Maywood). 2023 Jan;248(2):130-145. doi: 10.1177/15353702221142607. Epub 2022 Dec 13. Exp Biol Med (Maywood). 2023. PMID: 36511103 Free PMC article.

8

Circ_0001060 Upregulates and Encourages Progression in Osteosarcoma.

Liu H, Huang Q, Tang H, Luo K, Qin Y, Li F, Tang F, Zheng J, Feng W, Li B, Xie T, Liu Y. Liu H, et al. Among authors: liu y. DNA Cell Biol. 2023 Jan;42(1):53-64. doi: 10.1089/dna.2022.0500. Epub 2022 Dec 29. DNA Cell Biol. 2023. PMID: 36580535

9

Trends of denosumab-related publications in web of science.

Jiang X, Xie T, Feng W, Qin Z, Liao S, Liu Y, Lu S, He M, Wei Q. Jiang X, et al. Among authors: liu y. Medicine (Baltimore). 2023 Jan 27;102(4):e32784. doi: 10.1097/MD.0000000000032784. Medicine (Baltimore). 2023. PMID: 36705356 Free PMC article. Review.

10

A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes.

Tang H, Liu S, Luo X, Sun Y, Li X, Luo K, Liao S, Li F, Liang J, Zhan X, Wei Q, Liu Y, He M. Tang H, et al. Among authors: liu y, liu s. Front Immunol. 2023 Apr 6;14:1150588. doi: 10.3389/fimmu.2023.1150588. eCollection 2023. Front Immunol. 2023. PMID: 37090691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190,802 results

Search Page